Disease/Infection News

RSS

New prevention zone to protect poultry and captive birds from avian influenza

From 8pm on 21 November 2021, a new avian influenza prevention zone will be declared in parts of North Yorkshire in England, namely the districts of Harrogate, Hambleton and Richmondshire, which means that it is a legal requirement for all bird keepers in that area to keep their birds indoors and to follow strict biosecurity measures in order to limit the spread of and eradicate the disease.

21 Nov 2021

Sheep at low-risk for infection with SARS-CoV-2

A team of scientists from the US has recently evaluated the susceptibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in sheep. The findings reveal that sheep are generally less susceptible to SARS-CoV-2 infection. However, the susceptibility is relatively higher for the alpha variant of the virus. The study is currently available on the bioRxiv preprint server.

21 Nov 2021

U of U Health supports Governor’s decision to authorize COVID-19 booster doses for all adults in Utah

University of Utah Health supports Governor Spencer Cox’s decision to authorize booster doses of COVID-19 vaccines for all people living in Utah who are aged 18 and older.

21 Nov 2021

Study underscores why COVID-19 vaccine boosters are important for all adults

As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.

21 Nov 2021

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors -; a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions -; generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.

21 Nov 2021

New evidence that host immunity drives evolution of the dengue virus

New research by a team of University of Florida investigators, and others, provides evidence that host immunity drives evolution of the dengue virus.

20 Nov 2021

Creating a timeline that details the earliest COVID-19 cases in Wuhan

In a Perspective, Michael Worobey provides an overview of the crucial events that occurred between December 2019 and January 2020 in Wuhan, China, creating a timeline detailing the earliest cases of COVID-19, their connections to the Hunan Market where live animals were sold, and the events that led to SARS-CoV-2's formal identification as a novel virus.

20 Nov 2021

CDC posts food safety alert about multistate outbreak of E. coli O157 infections linked to spinach

A CDC food safety alert regarding a multistate outbreak of E. coli O157 infections linked to spinach has been posted: https://www.cdc.gov/ecoli/2021/o157h7-11-21/index.html.

20 Nov 2021

CDC expands recommendations for COVID-19 booster dose to include all adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) expanded recommendations for booster shots to include all adults ages 18 years and older who received a Pfizer-BioNTech or Moderna vaccine at least six months after their second dose.

19 Nov 2021

Risk of adverse pregnancy outcomes from SARS-CoV-2 likely lower than previously suggested

The risk of adverse pregnancy outcomes in women who tested positive for SARS-CoV-2 is likely lower than several earlier studies have suggested, a national study of all pregnant Swedish women tested for SARS-CoV-2 between March 2020 and January 2021 reports.

19 Nov 2021

Effectiveness of COVID-19 vaccination during Delta variant predominance

A new study investigated the continued effectiveness of COVID-19 vaccination during the delta variant predominance in a diverse and urban healthcare setting.

19 Nov 2021

Functions of glycosylation in SARS-CoV-2 proteins and human receptor ACE2

In a review published in Signal Transduction and Targeted Therapy, researchers from Sichuan University have reviewed the available literature.

19 Nov 2021

World Antimicrobial Awareness Week 2021: An Interview with Pan American Health Organization (PAHO)

For World Antimicrobial Awareness Week (WAAW) 2021, we spoke to Dr. Pilar Ramon Pardo from the Pan American Health Organization.

19 Nov 2021

Comparing effectiveness of virus and patients-centered strategies to reduce COVID-19 mortality

Researchers from Sorbonne Université have been reviewing papers exploring different anti-COVID-19 drugs.

19 Nov 2021

First long-acting injectable HIV treatment appraised and approved by NICE

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

19 Nov 2021

COVID-19 induced excess mortality

A new study presented a generalized linear mixed model to determine the rate of mortality related to COVID-19 infection in Lombardy, Italy.

19 Nov 2021

Can you take the COVID-19 and Influenza vaccines on the same day?

Scientists have conducted a substudy within a phase 3 UK trial and have reported the safety, immunogenicity, and efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with licensed seasonal influenza vaccines.

19 Nov 2021

Predicting the capacity of mammal species to become zoonotic SARS-CoV-2 hosts

Researchers identified a subset of species in which the threat of spillback infection appears the most significant due to location and increased contact with humans in areas with a high prevalence of SARS-CoV-2.

19 Nov 2021

Viral biomolecular condensation

A review published in PLOS Pathogens deconstructs virus condensation and provides a biochemical background for LLPS.

19 Nov 2021

Population-based risk compensation may have been a driving force in UK's COVID pandemic

The COVID-19 pandemic has irreversibly altered our lives in many ways. However, available COVID vaccines are effective against (symptomatic) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hospitalizations, and even death. Despite a diminishing protective effect against infection and onward transmission after vaccination, and a slightly diminished effect with the Delta variant compared to the Alpha variant, protection against severe outcomes remains high.

19 Nov 2021